Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

"Dub"bing a tumor suppressor pathway.

Wojciech Niedzwiedz¹, Ketan J Patel

¹MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom.

|February 16, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of IGF-1R impairs DNA-PKcs recruitment to chromatin leading to defective end-joining.

Molecular oncology·2026

Same author

Clock-like mutational signatures: Linking ageing to endogenous cancer risk.

Ageing research reviews·2026

Same author

Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis.

Cell stem cell·2026

Same author

Molecular basis of XPF-ERCC1 targeting to SLX4-dependent DNA repair pathways.

Nature communications·2025

Same author

The CIP2A-TOPBP1 axis facilitates mitotic DNA repair via MiDAS and MMEJ.

Nature communications·2025

Same author

Embracing cancer complexity: Hallmarks of systemic disease.

Cell·2024

Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026

Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026

Same journal

Intratumoral B cells under stress.

Cancer cell·2026

Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026

Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026

Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026

See all related articles

Fanconi anemia (FA) involves bone marrow failure and cancer risk due to genomic instability. Researchers identified a novel enzyme that deactivates FANCD2, regulating this critical DNA repair pathway.

Area of Science:

Genetics and Molecular Biology
Cancer Research
Hematology

Background:

Fanconi anemia (FA) is an autosomal recessive disorder characterized by bone marrow failure and a high risk of cancer.
FA patients' cells exhibit chromosome instability, highlighting the role of FA gene products in maintaining genomic integrity.
Key FA proteins form a nuclear complex that monoubiquitinates FANCD2, a crucial step for DNA repair at sites of damage.

Purpose of the Study:

To identify and characterize novel regulators of the Fanconi anemia pathway.
To understand the mechanisms controlling FANCD2 activation and deactivation in response to DNA damage.
To elucidate the role of specific enzymes in maintaining genomic stability in FA.

Main Methods:

Biochemical assays to identify enzyme activity.

Related Experiment Videos

Ubiquitination and deubiquitination assays for FANCD2.

Cell-based assays to assess DNA repair and genomic integrity.

Main Results:

Identification of a novel enzyme responsible for FANCD2 deactivation.
Demonstration that this enzyme regulates the Fanconi anemia pathway.
Evidence suggesting the enzyme plays a role in controlling FANCD2 levels at DNA damage sites.

Conclusions:

A newly discovered enzyme deactivates FANCD2, providing a critical regulatory mechanism for the Fanconi anemia pathway.
This finding offers new insights into maintaining genomic stability and potentially treating FA-related conditions.
Targeting this deactivating enzyme could represent a future therapeutic strategy for Fanconi anemia.